Posted: February 2017 By Cynthia L. Kryder, MS Clinical trials are essential to the development of new, potentially lifesaving therapies for patients with cancer. Well-designed clinical trials contribute to medical […] Read more
Posted: February 2017 By Lori Alexander, MTPW, ELS, MWC WCLC 2016 offered focused education for nurses and allied health professionals through its nursing track, as well as through special nursing […] Read more
Posted: February 2017 By Lori Alexander, MTPW, ELS, MWC The closing plenary session at IASLC WCLC 2016 featured several highly regarded oncologists who have devoted the greater part of their […] Read more
Posted: February 2017 By Caicun Zhou, MD As part of an ongoing series, IASLC Lung Cancer News is exploring how drug approval processes differ country by country, and continent by […] Read more
Posted: February 2017 By John K. Field, PhD, FRCPath, and James L. Mulshine, MD, PhD The Fourth IASLC Screening Strategy Advice Committee (SSAC) computed tomography (CT) screening workshop was held […] Read more
Posted: February 2017 Q&A with with Ronan J. Kelly, MB BCh, MBA Q: What is the impetus for the development of clinical pathways? A: The incidence of cancer in the US […] Read more
Alectinib (Alecensa) received a positive opinion from the European Medicines Agency (EMA) for Medicinal Products for Human Use (CHMP) for the treatment of adult patients with advanced anaplastic lymphoma kinase […] Read more
First Congress of Interventional Pulmonology & EBUS and the XI South American Bronchology Congresses
Posted: February 2017 By Luis E. Raez, MD, FACP, FCCP The First Congress of Interventional Pulmonology & Endobronchial Ultrasound (EBUS) and the XI South American Bronchology Congresses were both a […] Read more
Posted: February 2017 By Chee-Keong Toh, MD, and Daniel SW Tan, MD The recent decade has seen much interest in lung cancer in never-smokers (LCNS), in most part attributed to […] Read more
Posted: February 2017 Sumitra Thongprasert received the 2016 IASLC Merit Award, which is given to lung cancer specialists who have made extraordinary contributions to the IASLC’s development. Dr. Thongprasert is Professor […] Read more